Safety, tolerability and efficacy of linezolid for the treatment of M/XDR-TB: A systematic review and meta-analysis
G. Sotgiu, H. Anger, R. Centis, L. D‘Ambrsoio, S. De Lorenzo, C. Lange, G. F. Schecter, T. S. Shim, A. Skrahina, M. Villar, E. Zampogna, J. P. Zellweger, G. B. Migliori (Sassari, Tradate, Sondalo, Italy; New York, Richmond, United States Of America; Borstel, Germany; Seoul, Republic Of Korea; Minsk, Belarus; Amadora, Portugal; Lausanne, Switzerland)
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Session: Treatment of tuberculosis and adverse drug reactions
Session type: Thematic Poster Session
Number: 4399
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Sotgiu, H. Anger, R. Centis, L. D‘Ambrsoio, S. De Lorenzo, C. Lange, G. F. Schecter, T. S. Shim, A. Skrahina, M. Villar, E. Zampogna, J. P. Zellweger, G. B. Migliori (Sassari, Tradate, Sondalo, Italy; New York, Richmond, United States Of America; Borstel, Germany; Seoul, Republic Of Korea; Minsk, Belarus; Amadora, Portugal; Lausanne, Switzerland). Safety, tolerability and efficacy of linezolid for the treatment of M/XDR-TB: A systematic review and meta-analysis. Eur Respir J 2011; 38: Suppl. 55, 4399
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
The efficacy and safety of adjunctive corticosteroids in the treatment of tuberculous pleurisyA systematic review and meta-analysis Source: International Congress 2017 – TB: diagnosis, severity and practical management Year: 2017
The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection Year: 2019
Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China Source: Eur Respir J 2015; 45: 161-170 Year: 2015
Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China Source: Eur Respir J 2016; 47:1591-1592 Year: 2016
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis Source: Eur Respir J 2012; 40: 1430-1442 Year: 2012
Efficacy and tolerability of ethionamide versus prothionamide: a systematic review Source: Eur Respir J 2016; 48: 946-952 Year: 2016
Fixed-dose combination antituberculosis therapy: a systematic review and meta-analysis Source: Eur Respir J 2013; 42: 721-732 Year: 2013
Clinical effectiveness of triple therapy in the management of COPD: A systematic review Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010
The safety of cardioselective ß1 -blockers in asthma: literature review and search of global pharmacovigilance safety reports Source: ERJ Open Res, 7 (1) 00801-2020; 10.1183/23120541.00801-2020 Year: 2021
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study Source: Eur Respir J, 49 (5) 1700387; 10.1183/13993003.00387-2017 Year: 2017
On linezolid efficacy and tolerability Source: Eur Respir J 2012; 39: 770-772 Year: 2012
Efficacy of psychosocial intervention in COPD: a systematic review and meta-analysis Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation Year: 2020
A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis Source: Eur Respir J 2009; 33: 387-393 Year: 2009
Efficacy and safety of meropenem–clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB Source: Eur Respir J 2013; 41: 1386-1392 Year: 2013
Evaluation of efficacy and safety of linezolid for the treatment of drug-resistant tuberculosis: case series report of 12 patients Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance Year: 2009
Efficacy and safety profile of xanthines in COPD: a network meta-analysis Source: Eur Respir Rev, 27 (148) 180010; 10.1183/16000617.0010-2018 Year: 2018
Efficacy and safety profile of xanthines in COPD: a network meta-analysis Source: International Congress 2018 – Innovative therapies in asthma and COPD Year: 2018
Efficacy and tolerability of linezolid in the treatment of MDR-TB cases: a TBNET study in Germany and Italy Source: Annual Congress 2008 - Multidrug-resistant and the emerging threat of extensively drug-resistant tuberculosis Year: 2008
Efficacy and safety of new drugs for M/XDR-TB: what have we learned from observational studies? Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis Year: 2019
Evaluation of the efficacy and safety of levofloxacin in the treatment of resistant pulmonary tuberculosis; a clinical trial Source: Eur Respir J 2002; 20: Suppl. 38, 546s Year: 2002